中华医学会
地址: 中国北京东四西大街42号
邮编: 100710
2022年欧洲新生儿呼吸窘迫综合征管理指南更新要点解读
导读:该文介绍2022年欧洲新生儿RDS管理指南,重点介绍其更新要点。该指南主要适用于胎龄>24周新生儿RDS的管理,可为临床新生儿RDS规范化和精细化管理提供参考。
摘要
随着临床研究的深入,新生儿呼吸窘迫综合征(respiratory distress syndrome,RDS)的管理需优化和改进。该文旨在介绍2022年欧洲新生儿RDS管理指南,重点介绍其更新要点。该指南对早产风险预测、产妇转诊、产前糖皮质激素的应用、肺保护性通气策略的应用,以及RDS患儿的一般护理等方面的管理进行了优化。该指南主要适用于胎龄>24周新生儿RDS的管理。
关键词:呼吸窘迫综合征;指南解读;新生儿
正文 上下滑动查看 ↕ [1] Haumont D, Modi N, Saugstad OD, et al. Evaluating preterm care across Europe using the eNewborn European Network database[J]. Pediatr Res, 2020, 88(3): 484-495. PMID: 31972855. DOI: 10.1038/s41390-020-0769-x. [2] Sweet D, Bevilacqua G, Carnielli V, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome[J]. J Perinat Med, 2007, 35(3): 175-186. PMID: 17480144. DOI: 10.1515/JPM.2007.048. [3] Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants: 2010 update[J]. Neonatology, 2010, 97(4): 402-417. PMID: 20551710. DOI: 10.1159/000297773. [4] Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome: 2019 update[J]. Neonatology, 2019, 115(4): 432-450. PMID: 30974433. PMCID: PMC6604659. DOI: 10.1159/000499361. [5] Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome: 2016 update[J]. Neonatology, 2017, 111(2): 107-125. PMID: 27649091. DOI: 10.1159/000448985. [6] Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants: 2013 update[J]. Neonatology, 2013, 103(4): 353-368. PMID: 23736015. DOI: 10.1159/000349928. [7] Sweet DG, Carnielli VP, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome: 2022 update[J]. Neonatology, 2023, 120(1): 3-23. PMID: 36863329. PMCID: PMC10064400. DOI: 10.1159/000528914. [8] Duley L, Meher S, Hunter KE, et al. Antiplatelet agents for preventing pre-eclampsia and its complications[J]. Cochrane Database Syst Rev, 2019, 2019(10): CD004659. PMID: 31684684. PMCID: PMC6820858. DOI: 10.1002/14651858.CD004659.pub3. [9] EPPPIC Group. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials[J]. Lancet, 2021, 397(10280): 1183-1194. PMID: 33773630. DOI: 10.1016/S0140-6736(21)00217-8. [10] Melchor JC, Khalil A, Wing D, et al. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2018, 52(4): 442-451. PMID: 29920825. DOI: 10.1002/uog.19119. [11] Daskalakis G, Pergialiotis V, Domellöf M, et al. European guidelines on perinatal care: corticosteroids for women at risk of preterm birth[J]. J Matern Fetal Neonatal Med, 2023, 36(1): 2160628. PMID: 36689999. DOI: 10.1080/14767058.2022.2160628. [12] Ehret DEY, Edwards EM, Greenberg LT, et al. Association of antenatal steroid exposure with survival among infants receiving postnatal life support at 22 to 25 weeks' gestation[J]. JAMA Netw Open, 2018, 1(6): e183235. PMID: 30646235. PMCID: PMC6324435. DOI: 10.1001/jamanetworkopen.2018.3235. [13] Räikkönen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children[J]. JAMA, 2020, 323(19): 1924-1933. PMID: 32427304. PMCID: PMC7237984. DOI: 10.1001/jama.2020.3937. [14] McGoldrick E, Stewart F, Parker R, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth[J]. Cochrane Database Syst Rev, 2020, 12(12): CD004454. PMID: 33368142. PMCID: PMC8094626. DOI: 10.1002/14651858.CD004454.pub4. [15] 中国医师协会新生儿科医师分会, 《中华围产医学杂志》编辑委员会. 早产儿呼吸窘迫综合征早期防治专家共识[J]. 中华围产医学杂志, 2017, 20(8): 557-559. DOI: 10.3760/cma.j.issn.1007-9408.2017.08.002. [16] Jasani B, Torgalkar R, Ye XY, et al. Association of umbilical cord management strategies with outcomes of preterm infants: a systematic review and network meta-analysis[J]. JAMA Pediatr, 2021, 175(4): e210102. PMID: 33683307. PMCID: PMC7941254. DOI: 10.1001/jamapediatrics.2021.0102. [17] 中国医师协会新生儿科医师分会, 中国妇幼保健协会新生儿保健专业委员会, 《发育医学电子杂志》编辑委员会. 胎盘输血专家共识[J]. 发育医学电子杂志, 2021, 9(4): 241-247. DOI: 10.3969/j.issn.2095-5340.2021.04.001. [18] Subramaniam P, Ho JJ, Davis PG. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants[J]. Cochrane Database Syst Rev, 2021, 10(10): CD001243. PMID: 34661278. PMCID: PMC8521644. DOI: 10.1002/14651858.CD001243.pub4. [19] 中国新生儿复苏项目专家组, 中华医学会围产医学分会新生儿复苏学组. 中国新生儿复苏指南(2021年修订)[J]. 中华围产医学杂志, 2022, 25(1): 4-12. DOI: 10.3760/cma.j.cn113903-20211122-00967. [20] 中华医学会儿科学分会新生儿学组, 中华儿科杂志编辑委员会. 中国新生儿肺表面活性物质临床应用专家共识(2021版)[J]. 中华儿科杂志, 2021, 59(8): 627-632. PMID: 34333913. DOI: 10.3760/cma.j.cn112140-20210329-00261. [21] Abdel-Latif ME, Davis PG, Wheeler KI, et al. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome[J]. Cochrane Database Syst Rev, 2021, 5(5): CD011672. PMID: 33970483. PMCID: PMC8109227. DOI: 10.1002/14651858.CD011672.pub2. [22] Reynolds P, Bustani P, Darby C, et al. Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline[J]. Neonatology, 2021, 118(5): 586-592. PMID: 34515188. DOI: 10.1159/000518396. [23] Roberts KD, Brown R, Lampland AL, et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial[J]. J Pediatr, 2018, 193: 40-46.e1. PMID: 29174079. DOI: 10.1016/j.jpeds.2017.09.068. [24] 亚太卫生健康协会儿科医学分会, 亚太卫生健康协会儿科医学分会重症超声医学专业委员会, 世界重症超声联盟中国联盟, 等. 新生儿呼吸窘迫综合征超声诊断与分度专家共识[J]. 中国小儿急救医学, 2021, 28(7): 545-551. DOI: 10.3760/cma.j.issn.1673-4912.2021.07.001. [25] Capasso L, Pacella D, Migliaro F, et al. Can lung ultrasound score accurately predict the need for surfactant replacement in preterm neonates? A systematic review and meta-analysis protocol[J]. PLoS One, 2021, 16(7): e0255332. PMID: 34320032. PMCID: PMC8318286. DOI: 10.1371/journal.pone.0255332. [26] Liu T, Tomlinson LA, Yu Y, et al. Changes in institutional oxygen saturation targets are associated with an increased rate of severe retinopathy of prematurity[J]. J AAPOS, 2022, 26(1): 18.e1-18.e6. PMID: 35032651. DOI: 10.1016/j.jaapos.2021.10.002. [27] Ramaswamy VV, More K, Roehr CC, et al. Efficacy of noninvasive respiratory support modes for primary respiratory support in preterm neonates with respiratory distress syndrome: systematic review and network meta-analysis[J]. Pediatr Pulmonol, 2020, 55(11): 2940-2963. PMID: 32762014. DOI: 10.1002/ppul.25011. [28] Ramaswamy VV, Bandyopadhyay T, Nanda D, et al. Efficacy of noninvasive respiratory support modes as postextubation respiratory support in preterm neonates: a systematic review and network meta-analysis[J]. Pediatr Pulmonol, 2020, 55(11): 2924-2939. PMID: 32757365. DOI: 10.1002/ppul.25007. [29] Li J, Chen L, Shi Y. Nasal high-frequency oscillatory ventilation versus nasal continuous positive airway pressure as primary respiratory support strategies for respiratory distress syndrome in preterm infants: a systematic review and meta-analysis[J]. Eur J Pediatr, 2022, 181(1): 215-223. PMID: 34254173. DOI: 10.1007/s00431-021-04190-0. [30] Bassler D, Shinwell ES, Hallman M, et al. Long-term effects of inhaled budesonide for bronchopulmonary dysplasia[J]. N Engl J Med, 2018, 378(2): 148-157. PMID: 29320647. DOI: 10.1056/NEJMoa1708831. [31] Garrido F, Gonzalez-Caballero JL, Lomax R, et al. The immediate efficacy of inhaled nitric oxide treatment in preterm infants with acute respiratory failure during neonatal transport[J]. Acta Paediatr, 2020, 109(2): 309-313. PMID: 31373038. DOI: 10.1111/apa.14958. [32] 国家儿童健康与疾病临床医学研究中心/儿童发育疾病研究教育部重点实验室/儿科学重庆市重点实验室/重庆医科大学附属儿童医院. 中国新生儿疼痛管理循证指南(2023年)[J]. 中国当代儿科杂志, 2023, 25(2): 109-127. PMID: 36854686. PMCID: PMC9979385. DOI: 10.7499/j.issn.1008-8830.2210052. [33] Ray S. Nice guideline review: neonatal parenteral nutrition (NG154)[J]. Arch Dis Child Educ Pract Ed, 2021, 106(5): 292-295. PMID: 33199498. DOI: 10.1136/archdischild-2020-320581. [34] Jochum F, Moltu SJ, Senterre T, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: fluid and electrolytes[J]. Clin Nutr, 2018, 37(6 Pt B): 2344-2353. PMID: 30064846. DOI: 10.1016/j.clnu.2018.06.948. [35] Capin I, Hinds A, Vomero B, et al. Are early-onset sepsis evaluations and empiric antibiotics mandatory for all neonates admitted with respiratory distress?[J]. Am J Perinatol, 2022, 39(4): 444-448. PMID: 32947642. DOI: 10.1055/s-0040-1717070. [36] Nestaas E. Neonatologist performed echocardiography for evaluating the newborn infant[J]. Front Pediatr, 2022, 10: 853205. PMID: 35402362. PMCID: PMC8987714. DOI: 10.3389/fped.2022.853205. [37] Rozé JC, Cambonie G, Marchand-Martin L, et al. Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm infants[J]. JAMA, 2015, 313(24): 2441-2448. PMID: 26103028. DOI: 10.1001/jama.2015.6734. [38] 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 5版. 北京: 人民卫生出版社, 2019: 743-745. [39] Mohamed MA, El-Dib M, Alqahtani S, et al. Patent ductus arteriosus in premature infants: to treat or not to treat?[J]. J Perinatol, 2017, 37(6): 652-657. PMID: 28206995. DOI: 10.1038/jp.2017.4. [40] Bell EF. Red cell transfusion thresholds for preterm infants: finally some answers[J]. Arch Dis Child Fetal Neonatal Ed, 2022, 107(2): 126-130. PMID: 33906941. DOI: 10.1136/archdischild-2020-320495.